Literature DB >> 10632007

Pathology of late endothelial failure: late endothelial failure of penetrating keratoplasty: study with light and electron microscopy.

K D Bell1, R J Campbell, W M Bourne.   

Abstract

PURPOSE: Late endothelial failure of penetrating keratoplasty can be defined as gradual decompensation (increasing thickness with loss of clarity) of a previously clear graft without apparent cause. This study examined the possibility that a chronic subclinical rejection process may be occurring in grafts that fail from late endothelial failure.
METHOD: Six patients fulfilling the diagnostic criteria for late endothelial failure who underwent repeated keratoplasty were studied. The clinical course and results of specular microscopy were reviewed. The failed corneal graft for each patient was examined by light and electron microscopy.
RESULTS: Sequential specular microscopy demonstrated low initial postoperative endothelial cell density with continued decrease in density and increase in corneal thickness over the first 5 postoperative years. Electron microscopy revealed irregular-shaped cells of varying size with many abnormal features, lying on abnormal Descemet's membrane. Degenerating endothelial cells were commonly seen. There was no sign of acute or chronic inflammation.
CONCLUSIONS: The pathologic findings are suggestive of an unstable and highly stressed endothelial cell population in late endothelial failure but are nonspecific. There was no evidence of acute or chronic rejection at the time of graft failure.

Entities:  

Mesh:

Year:  2000        PMID: 10632007     DOI: 10.1097/00003226-200001000-00009

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  25 in total

1.  A Two-Piece Microkeratome-Assisted Mushroom Keratoplasty Improves the Outcomes and Survival of Grafts Performed in Eyes with Diseased Stroma and Healthy Endothelium (An American Ophthalmological Society Thesis).

Authors:  Massimo Busin; Silvana Madi; Vincenzo Scorcia; Paolo Santorum; Yoav Nahum
Journal:  Trans Am Ophthalmol Soc       Date:  2015

Review 2.  Graft failure: I. Endothelial cell loss.

Authors:  Ilse Claerhout; Hilde Beele; Philippe Kestelyn
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

3.  Establishment of a murine model of chronic corneal allograft dysfunction.

Authors:  Hua Gao; Weiyun Shi; Huaqing Gong; Yiqiang Wang; Ye Wang; Lixin Xie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-16       Impact factor: 3.117

4.  Keratocyte and subbasal nerve density after penetrating keratoplasty.

Authors:  Sanjay V Patel; Jay C Erie; Jay W McLaren; William M Bourne
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 5.  Graft survival and endothelial outcomes in the new era of endothelial keratoplasty.

Authors:  Sanjay V Patel
Journal:  Exp Eye Res       Date:  2011-06-15       Impact factor: 3.467

6.  CTCF mediates effect of insulin on glucagon expression.

Authors:  Shanli Tsui; Jie Gao; Charles Wang; Luo Lu
Journal:  Exp Cell Res       Date:  2012-03-08       Impact factor: 3.905

7.  Corneal endothelial autocrine VIP enhances its integrity in stored human donor corneoscleral explant.

Authors:  Shay-Whey M Koh; Dante Gloria; Joseph Molloy
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

8.  Donor risk factors for graft failure in a 20-year study of penetrating keratoplasty.

Authors:  Sanjay V Patel; Nancy N Diehl; David O Hodge; William M Bourne
Journal:  Arch Ophthalmol       Date:  2010-04

9.  Role of CTCF in EGF-induced migration of immortalized human corneal epithelial cells.

Authors:  Ling Wang; Sophie X Deng; Luo Lu
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-23       Impact factor: 4.799

Review 10.  Corneal endothelial autocrine trophic factor VIP in a mechanism-based strategy to enhance human donor cornea preservation for transplantation.

Authors:  Shay-Whey Margaret Koh
Journal:  Exp Eye Res       Date:  2011-10-25       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.